Matthew W. Emmens
"Matthew Emmens, age 67, brings to the Board of Bristol-Myers Squibb more than 40 years of experience in the biopharmaceutical industry, with significant management, business development and operations expertise. Mr. Emmens began his career in international pharmaceuticals with Merck & Co., Inc., where he helped to establish Astra Merck, the joint venture between Merck and Astra AB of Sweden, later becoming its President and CEO. A recognized biotech and pharma leader, Mr. Emmens served as President, Pharmaceuticals, for Merck KGaA from 1999 until 2003; Chief Executive Officer and Chairman of Shire PLC from 2003 until 2008; and President, Chief Executive Officer and Chairman of Vertex Pharmaceuticals from 2004 until 2009. While at Shire, Mr. Emmens engineered an extraordinary revitalization, transforming Shire into one of the top specialty biopharma companies in the world. " 
Resources and articles
- Bristol-Myers Squibb Board, organizational web page, accessed April 5, 2020.